Block 2: Inflammation and Eicosanoids Flashcards
Histamine: source, physiological response, mechanism
source: mast cells and basophils
response: vasodilation, increased vascular permeability, pain
mechanism: activation of GPCRs
Bradykinin: what is it, source, physiological response, mechanism
type: vasoactive peptide
source: endothelial cells
response: vasodilation, increased microvessel permeability, pain
mechanism: activation of GPCRs
Elevated CRP is associated with what?
increased risk of diabetes, hypertension, and cardiovascular disease
Cytokines: two pro-inflammatory examples, how they cause fever
IL-1, TNF-alpha
Increased expression of cyclooxygenase in hypothalamus -> increased formation of PGE2 which acts via cAMP to reset temperature set-point in hypothalamus -> increase body temp.
Prostaglandin: what is it, physiological response, mechanism
pro-inflammatory lipid mediator
response: vasodilation/vasoconstriction, pain, fever, platelet aggregation
mechanism: activation of specific GPCRs
Glucocorticoids: what they are, source, physiological response, mechanism
anti-inflammatory lipid mediators that inhibit arachidonic acid release
source: adrenal cortex
response: decrease expression of COX-2 and inhibits phospholipase-A2 (enzyme that cleaves phospholipid and releases arachidonic acid)
mechanism: activation of nuclear receptors
Leukotrienes: what is it, source, physiological response, mechanism
pro-inflammatory lipid mediator
response: increased vascular permeability, chemoattractant for neutrophils, bronchoconstriction
mechanism: activation of GPCRs
NSAIDs: mechanism
inhibition of cyclooxygenase, reduces production of inflammatory prostanoids
zafirlukast and zileuton: what each of them are, theapeutic use
zafirlukasat: competitve antagonist of leukotriene receptors
zileuton: inhibits 5-lipoxygenase and thus the synthesis of leukotrienes
use: prophylaxis and chronic treatment of asthma
TNF inhibitors (2)
etanercept, infliximab
etanercept and infliximab
TNF inhibitors
etanercept: receptor analog
infliximab: monoclonal antibody
precursor of eicosanoids
arachidonic acid
what enzyme synthesizes leukotrienes and from what precursor?
5-lipoxygenase from arachidonic acid
prophylaxis and chronic treatment of asthma (2)
zileuton and zafirlukast
Complement system: source, physiological response, mechanism
source: synthesized by liver, circulate in blood
physiological response: chemotaxis, release of mediators from neutrophils, increase vascular permeability
mechanism: complement complexes cause osmotic lysis, activation of GPCRs
Cytokines: physiological response, mechanism
physiological response:
TNF-alpha: fever, sepsis
IL-1: fever, fibroblast and lymphocyte proliferation
mechanism:
1. increase cyclooxygenase and lipoxygenase
2. increase adhesion molecule expression
3. induce collagenase (fibrosis)
function of phospholipase A2
hydrolyzes phospholipids to release arachidonic acid
function of cyclooxygenase
converts free arachidonic acid to PGH2 which is transformed enzymatically to prostacyclin, thromboxane, PGE2, PGF2
difference between COX-1 and COX-2
COX-1 is constitutive and expresed in all tissues
COX-2 is inducible and is more commonly seen in inflammation
function of 5-lipoxygenase
synthesize leukotrienes from arachidonic acid
types of drugs that inhibit phospholipase A2
glucocorticoids
type of drug that inhibit COX-1 and COX-2
NSAIDs
type of drug that decrease expression only of COX-2
glucocorticoids
inhibitors of lipoxygenase
zileuton and zafirlukast